PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding PMV Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 92 | 2 | 105 | +15 |
| Shares | 44.0M | 31.7K | 47.5M | +3.51M (+8.0%) |
| Value | $1.31B | $945.0K | $1.10B | −$213.4M (−16.3%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (9)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Logos Global Management LP | 1,400,000 | $41.7M |
| Octagon Capital Advisors LP | 100,141 | $2.98M |
| Adage Capital Partners GP, L.L.C. | 53,000 | $1.58M |
| Driehaus Capital Management LLC | 35,000 | $1.04M |
| Atom Investors LP | 27,199 | $811.0K |
| TD Asset Management Inc | 17,600 | $524.0K |
| Marshall Wace, LLP | 12,716 | $379.0K |
| PDT Partners, LLC | 8,610 | $257.0K |
| Signaturefd, LLC | 29 | $1.00K |
Not filed for Q4 2021 yet (2)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Freed Investment Group | 24,880 | $741.0K |
| Marshall Wace North America L.P. | 6,848 | $204.0K |